INTEGRA LIFESCIENCES HOLDINGS CORP Defined Benefit Plan, Expected Return (Loss) on Plan Assets
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Defined Benefit Plan, Expected Return (Loss) on Plan Assets of $2.12 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Compensation Related Costs › Defined Benefit Plan
us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets · last filed 2026-02-26
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, expected return (loss) on plan assets for the quarter ending 2014-03-31 was $134.00K, a 34.00% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, expected return (loss) on plan assets for the quarter ending 2013-12-31 was $107.00K.
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, expected return (loss) on plan assets for the quarter ending 2013-09-30 was $100.00K, a 29.58% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, expected return (loss) on plan assets for the quarter ending 2013-06-30 was $100.00K, a 31.03% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, expected return (loss) on plan assets for fiscal 2025 was $2.12M, a 29.16% increase from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, expected return (loss) on plan assets for fiscal 2024 was $1.64M, a 13.03% increase from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, expected return (loss) on plan assets for fiscal 2023 was $1.45M, a 5.00% increase from fiscal 2022.
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, expected return (loss) on plan assets for fiscal 2022 was $1.38M, a 54.65% increase from fiscal 2021.
| Period end | Defined Benefit Plan, Expected Return (Loss) on Plan Assets 3 month | Defined Benefit Plan, Expected Return (Loss) on Plan Assets 6 month | Defined Benefit Plan, Expected Return (Loss) on Plan Assets 9 month | Defined Benefit Plan, Expected Return (Loss) on Plan Assets 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.12M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $1.64M 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $1.45M 10-K · filed 2026-02-26 | |||
| 2022-12-31 | $1.38M 10-K · filed 2024-02-28 | |||
| 2021-12-31 | $893.00K 10-K · filed 2023-02-22 | |||
| 2020-12-31 | $652.00K 10-K · filed 2022-02-24 | |||
| 2019-12-31 | $1.05M 10-K · filed 2021-02-23 | |||
| 2018-12-31 | $944.00K 10-K · filed 2020-02-21 | |||
| 2017-12-31 | $224.00K 10-K · filed 2019-02-26 | |||
| 2014-12-31 | $511.00K 10-K · filed 2015-02-27 | |||
| 2014-03-31 | $134.00K 10-Q · filed 2014-05-01 | $241.00K derived: sum of 2 quarters · filed 2015-02-27 | $341.00K derived: sum of 3 quarters · filed 2015-02-27 | $441.00K derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-12-31 | $107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $207.00K derived: sum of 2 quarters · filed 2015-02-27 | $307.00K derived: sum of 3 quarters · filed 2015-02-27 | $407.00K 10-K · filed 2015-02-27 |
| 2013-09-30 | $100.00K 10-Q · filed 2013-10-30 | $200.00K derived: sum of 2 quarters · filed 2013-10-30 | $300.00K 10-Q · filed 2013-10-30 | $260.00K derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $100.00K 10-Q/A · filed 2013-08-02 | $200.00K 10-Q/A · filed 2013-08-02 | $160.00K derived: sum of 3 quarters · filed 2015-02-27 | $302.00K derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $100.00K 10-Q · filed 2014-05-01 | $60.00K derived: sum of 2 quarters · filed 2015-02-27 | $202.00K derived: sum of 3 quarters · filed 2015-02-27 | $347.00K derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | -$40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $102.00K derived: sum of 2 quarters · filed 2015-02-27 | $247.00K derived: sum of 3 quarters · filed 2015-02-27 | $392.00K 10-K · filed 2015-02-27 |
| 2012-09-30 | $142.00K 10-Q · filed 2013-10-30 | $287.00K derived: sum of 2 quarters · filed 2013-10-30 | $432.00K 10-Q · filed 2013-10-30 | $577.00K derived: sum of 4 quarters · filed 2014-06-20 |
| 2012-06-30 | $145.00K 10-Q/A · filed 2013-08-02 | $289.00K 10-Q/A · filed 2013-08-02 | $435.00K derived: sum of 3 quarters · filed 2014-06-20 | $582.00K derived: sum of 4 quarters · filed 2014-06-20 |
| 2012-03-31 | $144.00K 10-Q · filed 2013-05-02 | $290.00K derived: sum of 2 quarters · filed 2014-06-20 | $437.00K derived: sum of 3 quarters · filed 2014-06-20 | $586.00K derived: sum of 4 quarters · filed 2014-06-20 |
| 2011-12-31 | $146.00K derived: 8-K 12 month − 10-Q 9 month · filed 2014-06-20 | $293.00K derived: sum of 2 quarters · filed 2014-06-20 | $442.00K derived: sum of 3 quarters · filed 2014-06-20 | $589.00K 8-K · filed 2014-06-20 |
| 2011-09-30 | $147.00K 10-Q · filed 2012-10-24 | $296.00K derived: sum of 2 quarters · filed 2012-10-24 | $443.00K 10-Q · filed 2012-10-24 | $589.00K derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-06-30 | $149.00K 10-Q · filed 2012-07-31 | $295.00K 10-Q · filed 2012-07-31 | $442.00K derived: sum of 3 quarters · filed 2013-02-26 | $566.00K derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-03-31 | $146.00K 10-Q · filed 2012-04-26 | $293.00K derived: sum of 2 quarters · filed 2013-02-26 | $417.00K derived: sum of 3 quarters · filed 2013-02-26 | $536.00K derived: sum of 4 quarters · filed 2013-02-26 |
| 2010-12-31 | $147.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $271.00K derived: sum of 2 quarters · filed 2013-02-26 | $390.00K derived: sum of 3 quarters · filed 2013-02-26 | $515.00K 10-K · filed 2013-02-26 |
| 2010-09-30 | $124.00K 10-Q · filed 2011-10-31 | $243.00K derived: sum of 2 quarters · filed 2011-10-31 | $368.00K 10-Q · filed 2011-10-31 | |
| 2010-06-30 | $119.00K 10-Q · filed 2011-08-01 | $244.00K 10-Q · filed 2011-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |